Royalty Pharma (RPRX)
(Real Time Quote from BATS)
$27.99 USD
+0.10 (0.36%)
Updated Apr 19, 2024 01:46 PM ET
3-Hold of 5 3
B Value D Growth A Momentum C VGM
Earnings News For RPRX
-
Royalty Pharma: Q4 Earnings Snapshot
-
Royalty Pharma: Q3 Earnings Snapshot
-
Royalty Pharma Reports Third Quarter 2023 Results
-
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Royalty Pharma (RPRX) Surpasses Q2 Earnings and Revenue Estimates
-
Royalty Pharma: Q2 Earnings Snapshot
-
Royalty Pharma Reports Second Quarter 2023 Results
-
Royalty Pharma (RPRX) Q1 Earnings and Revenues Top Estimates
-
Royalty Pharma: Q1 Earnings Snapshot
-
Royalty Pharma Reports First Quarter 2023 Results
-
Royalty Pharma (RPRX) Reports Next Week: Wall Street Expects Earnings Growth
-
Royalty Pharma (RPRX) Matches Q4 Earnings Estimates
-
Royalty Pharma: Q4 Earnings Snapshot
-
Royalty Pharma (RPRX) Surpasses Q3 Earnings and Revenue Estimates
-
Royalty Pharma: Q3 Earnings Snapshot
-
Royalty Pharma Reports Third Quarter 2022 Results
-
Royalty Pharma (RPRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates
-
Royalty Pharma: Q2 Earnings Snapshot
-
Royalty Pharma Reports Second Quarter 2022 Results
-
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Royalty Pharma (RPRX) Lags Q1 Earnings Estimates
-
Royalty Pharma (RPRX) Reports Next Week: Wall Street Expects Earnings Growth
-
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Royalty Pharma (RPRX) Tops Q3 Earnings and Revenue Estimates